2022 Publication list
2022 Publication list
2022年度（2022年4月―2023年3月）論文
| 1 | Takatsu F, Suzawa K, Okazaki M, Shien K, Yamamoto H, Watanabe M, Hayama M, Ueno T, Sugimoto R, Maki Y, Fujiwara T, Okita R, Inokawa H, Tao H, Hirami Y, Matsuda E, Kataoka K, Yamashita M, Sano Y, Matsuura M, Mizutani H, Toyooka S. Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck Cancer. Ann Thorac Surg 2022. |
| 2 | Tsubata Y, Hotta T, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Ohtsu H, Kobayashi K, Isobe T. Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study). Ther Adv Med Oncol 2022; 14:17588359221110171. |
| 3 | Okita R, Okada M, Inokawa H, Murakami T, Ikeda E. Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy. Surg Oncol 2022; 43:101813. |
| 4 | Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A, Tokioka F, Kadowaki T, Watanabe A, Fukui M, Kitajima T, Sato S, Tsuda T, Kishimoto N, Kita H, Mori Y, Nakayama M, Takahashi K, Tsuboi T, Yoshida M, Hataji O, Fuke S, Kagajo M, Nishine H, Kobayashi H, Nakamura H, Okuda M, Tachibana S, Takata S, Osoreda H, Minami K, Nishimura T, Ishida T, Terada J, Takeuchi N, Kohashi Y, Inoue H, Nakagawa Y, Kikuchi T, Tomii K. Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial. Am J Respir Crit Care Med 2022; 206:1326-35. |
| 5 | Tsubata Y, Kawakado K, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Hotta T, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Kobayashi K, Isobe T. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data. Int J Clin Oncol 2023; 28:69-78. |
| 6 | Harada D, Tamura T, Ninomiya K, Kubo T, Kuyama S, Tachibana S, Inoue K, Chikamori K, Kudo K, Ochi N, Maeda Y, Kiura K. Safety of anti-SARS-CoV-2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient-reported outcome study. Thorac Cancer 2023; 14:231-6.5. |
| 7 | Oishi K, Asami-Noyama M, Yamamoto T, Matsumori K, Yonezawa K, Watanabe M, Hisamoto Y, Fukatsu A, Matsuda K, Hamada K, Suetake R, Ohata S, Murata Y, Yamaji Y, Sakamoto K, Ito K, Osoreda H, Edakuni N, Kakugawa T, Hirano T, Matsunaga K. Detection of impaired gas exchange using the 1-minute sit-to-stand test in patients with interstitial lung disease. Respir Investig 2023; 61:186-9. |
| 8 | Okazaki M, Suzawa K, Shien K, Yamamoto H, Araki K, Watanabe M, Okada M, Maki Y, Ueno T, Otani S, Sugimoto R, Nishikawa H, Okita R, Hayama M, Tao H, Fujiwara T, Inokawa H, Hirami Y, Sano Y, Yamashita M, Kawamata O, Matsuura M, Toyooka S. Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy. Eur J Cardiothorac Surg 2023; 63. |
| 9 | Okita R, Mimura-Kimura Y, Kawamoto N, Yamamoto N, Umeda M, Okada M, Inokawa H, Mimura Y, Murakami T, Nakata M, Okabe K. Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy. Cancer Immunol Immunother 2023; 72:865-79. |
| 10 | Okita R, Kawamoto N, Okada M, Inokawa H, Yamamoto N, Murakami T, Ikeda E. Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis. Sci Rep 2023; 13:5263. |
| 11 | Tanaka N, Kunihiro Y, Kawano R, Yujiri T, Ueda K, Gondo T, Kobayashi T, Matsumoto T. Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT. Jpn J Radiol 2023; 41:27-37. |
| 12 | 三村雄輔（2022）ガラクトシル非フコシル化免疫グロブリン製剤の抗炎症作用. Glycoforum; 25(4) A11 |
| 13 | 田中伸幸（2022）読影力がグッと上がる！胸部X線写真・CTの読み方、考え方. 6．膠原病に関連した肺病変. レジデントノート増刊 24巻5号100-109 |
| 14 | 田中伸幸（2022）特集1：絶対苦手分野にしない市中肺炎の画像診断. ウイルス肺炎： COVID–19肺炎は除く. 臨床画像38巻5号530-538. |
| 15 | 石光雄太（2023）新型コロナウイルス感染症流行に伴うコロナフレイル予防の取り組み 理学療法ジャーナル57巻2号246-247 |
| 16 | 小牧隼人，石光雄太，徳弘郁絵，上野かおり，堀寛史（2023）新型コロナウイルス感染症対策による中学校休校から再開までの運動器・メンタルヘルスに関する予防・啓発活動. 日本予防理学療法学会雑誌２巻１号32-38 |
| 17 | 田中伸幸（2023）胸部X線診断再入門：症例から学ぶ読影法. 12. 肺胞性陰影と間質性陰影の特徴とは？ 画像診断43巻4号5112-5124. |